Are the TNF rs1800629 A allele and COMT rs4680 Met allele linked to higher inflammation and greater pain sensitivity?

Genetic variations in inflammatory and neurotransmitter pathways significantly influence an individual's systemic inflammatory profile, baseline pain thresholds, and stress-related pain processing.

Molecular mechanisms of inflammation

• Elevated TNF-alpha transcription: The TNF rs1800629 (G-308A) A allele is a functional promoter variant. By enhancing the binding of key transcription factors, this single nucleotide polymorphism drives up to a two- to three-fold increase in transcriptional activity.
• Heightened inflammatory response: This increased gene transcription directly elevates circulating and local levels of TNF-alpha protein. Consequently, carriers of the A allele experience more intense inflammatory phenotypes, particularly when cellular pathways are triggered by inflammatory stimuli.

Neurological pain and stress modulation

• Reduced COMT enzyme activity: The COMT rs4680 Met allele involves a valine-to-methionine (Val158Met) substitution that compromises the protein's thermostability at physiological body temperature. This results in accelerated thermal degradation, causing a substantial 60% to 75% (three- to four-fold) reduction in active enzyme capacity for homozygous Met/Met carriers.
• Increased pain sensitivity: Lower COMT activity elevates synaptic dopamine and norepinephrine levels in cortical and limbic regions, lowering sensory thresholds. Carriers exhibit heightened baseline pain sensitivity and elevated sensory and affective pain ratings.
• Impaired stress-related modulation: Under sustained pain stress, the Met allele alters descending pain-inhibitory controls. Reduced endogenous µ-opioid system recruitment and weaker dynamic µ-opioid receptor activation under distress prevent adequate endogenous analgesia. This molecular impairment manifests as reduced conditioned pain modulation (CPM) indices.

Bottom line

• The TNF rs1800629 A allele amplifies inflammatory responses through elevated TNF-alpha transcription, while the COMT rs4680 Met allele reduces enzyme activity by up to 75%, directly driving greater pain sensitivity and impairing the body's natural stress-induced opioid analgesia.